2024. Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration. Ukrainian Journal of Ophthalmology . 3 (Лип 2024), 28–32. DOI:https://doi.org/10.31288/oftalmolzh202432832.